Psoriasis and risk of myocardial infarction [6]

JAMA

Volumn 297, Issue 4, 2007, Pages 361-362

  Malerba, Mario ^a   Gisondi, Paolo ^b   Radaeli, Alessandro ^a   Girolomoni, Giampiero ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; INTESTINE ABSORPTION; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS; THROMBOCYTE ADHESION; DEPRESSION; IMMUNOLOGY; MENTAL STRESS; NOTE; PATHOPHYSIOLOGY; RISK FACTOR;

DEPRESSION; HUMANS; MYOCARDIAL INFARCTION; PSORIASIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 33846536792     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.4.361-b     Document Type: Letter

References (4)

1. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-1741.
2. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients [published online ahead of print August 30, 2006]. Atherosclerosis. 2007;190:1-9.
3. Malerba M, Gisondi P, Radaeli A, Sala R, Pinton PC, Girolomoni G. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol. 2006;155:1165-1169.
4. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 1997;277:1775-1781.